Aller au contenu principal
2023 article

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

1Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : pk. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

LettersMarch 2023Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 UpdateFarah Asif, MBBS, MScFarah Asif, MBBS, MScShaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PakistanAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L22-0489 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR: DeTora and colleagues' revised GPP guidelines (1) are helpful, and their publication is appreciated. I thank the authors for paying attention to inclusivity and addressing the needs of marginalized and minority groups. The initiative of considering inclusivity in publication steering committees and working groups by including colleagues from different geographic regions and with different job roles and varied demographic characteristics (such as sex or gender, race, and national origin) is very insightful. However, it should be kept in mind at all times that members of marginalized groups and low- and middle-income countries as well as women might ...Reference1. DeTora LM, Toroser D, Sykes A, et al. Good Publication Practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2022;175:1298-304. [PMID: 36037471] doi:10.7326/M22-1460 LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PakistanDisclosures: Authors have reported no disclosures of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L22-0489. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoGood Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update Lisa M. DeTora , Dikran Toroser , Angela Sykes , Christine Vanderlinden , Fiona J. Plunkett , Trevor Lane , Eline Hanekamp , Laura Dormer , Faith DiBiasi , Dan Bridges , Lise Baltzer , and Leslie Citrome Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update Lisa M. DeTora , Trevor Lane , Angela Sykes , Faith DiBiasi , Dikran Toroser , and Leslie Citrome Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update Robert Reinhard Metrics Current IssueMarch 2023Volume 176, Issue 3KeywordsClinical trialsDisclosureResearch ethicsResearch reporting guidelines ePublished: 21 March 2023 Issue Published: March 2023 Copyright & PermissionsCopyright © 2023 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
Date Crossref
01/03/2023
Éditeur
American College of Physicians
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Biomedical Ethics and RegulationPharmaceutical industry and healthcarePharmaceutical Economics and Policy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.